IQ Proteomics
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
39 Grant St Ste 400, Framingham, Massach...Website
www.iqproteomics.comRevenue
<$5 MillionIndustry
About IQ Proteomics
IQ Proteomics specializes in next-generation proteomic applications, offering optimized workflows for comprehensive proteome characterization. Their services include unbiased quantitative proteomics, drug target identification, and custom targeted assays across various biological matrices. Established in 2015, the company caters to pharmaceutical and biotechnology clients, providing actionable data with a focus on timely delivery. Located near Boston, MA, IQ Proteomics boasts dedicated facilities and advanced technology for high-throughput sample analysis and proteome informatics.Explore more
IQ Proteomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to IQ Proteomics
Compare insights from companies similar to IQ Proteomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
IQ Proteomics Tech Stack
A closer look at the technologies used by IQ Proteomics
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding IQ Proteomics
Sign Up For FreeTo access detailed company insights
IQ Proteomics specializes in next-generation proteomic applications, offering optimized workflows for comprehensive proteome characterization. Their services include unbiased quantitative proteomics, drug target identification, and custom targeted assays across various biological matrices. Established in 2015, the company caters to pharmaceutical a... Read More
